Clinical Trial Update: A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain [Phase 1]

View source ↗

Summary

This Clinical Trial Update reports a Phase 1 study by Janssen Research & Development to investigate regional brain kinetics of P-glycoprotein and BCRP substrate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• 11C-JNJ-63779586

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED